Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Cognitive Therapy for Suicidal Older Men

7 de junio de 2017 actualizado por: University of Pennsylvania
The primary aim of the proposed study is to compare the efficacy of cognitive therapy (CT) with the efficacy of an enhanced usual care (EUC) intervention for reducing the rate of suicide ideation (SI) and the severity of depression and hopelessness among older men. The investigators expect that suicidal older men randomly assigned to the CT intervention condition will have a lower rate of SI during the follow-up period than participants assigned to the control condition.

Descripción general del estudio

Estado

Terminado

Condiciones

Descripción detallada

Older adult males have the highest suicide rate of any age group in the U.S. However, most research concerning treatments for suicide ideation and behavior has focused on adolescents and young adults. Very few treatments have been developed to reduce suicide ideation and behavior in men aged 50 and above. This study will assess the effectiveness of specialized cognitive therapy versus enhanced usual care in treating older men with suicide ideation.

Participants in this five-year study will be randomly assigned to receive either cognitive therapy or enhanced usual care. Participants will be identified within the VA Medical Center and the University of Pennsylvania Health System (UPHS) as having experienced suicide ideation in the past month. Cognitive therapy will be provided by Ph.D.-level therapists and will be geared specifically toward older men with suicidal tendencies. The enhanced usual care condition will consist of the usual care that individuals receive for suicide prevention, plus assessment and referral services provided by independent evaluators and study case managers. In addition, patients in the enhanced usual care condition will receive weekly telephone calls from the study therapists. These phone calls will be approximately 15-30 minutes in duration and their purpose will be to ensure patient safety and to provide some support. All participants will be assessed pre-treatment to attain baseline measures of suicide ideation, hopelessness, and depression. Study visits will occur at baseline and Months 1, 3, 6, 9, and 12 to assess suicide ideation. Self-report and clinician-administered measures will be used to assess participants' progress.

Tipo de estudio

Intervencionista

Inscripción (Actual)

110

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Pennsylvania
      • Philadelphia, Pennsylvania, Estados Unidos, 19104
        • Aaron T. Beck Psychopathology Research Center - University of Pennsylvania

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

50 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Masculino

Descripción

Inclusion Criteria:

  1. Suicidal intent or desire during the past month prior to the baseline interview as indicated by a score of 1 or higher on items 4 or 5 of the Scale for Suicide Ideation.
  2. Male
  3. 50 years of age or older
  4. Able to speak English
  5. Able to provide written informed consent
  6. Able to attend study assessment and therapy sessions
  7. Able to provide at least two verifiable contacts for tracking purposes
  8. Able to function at an intellectual level to allow for the reliable completion of study assessments and participate in psychotherapy as indicated by a Mini-Mental Status Exam (MMSE) total score of 24 or higher and an Executive Interview (EXIT-25) total score of 14 or lower.

Exclusion Criteria:

  1. Needed priority treatment for a substance use disorder as determined by the referring clinician.
  2. Needed priority treatment for PTSD as determined by the referring clinician.
  3. Taking antidepressant medication for less than one month, or if antidepressant medication has been changed in the last month as indicated by the Alexopolous "Composite Antidepressant Score" Scale.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Cognitive Therapy
A cognitive therapy protocol specifically designed to target suicidal ideation in older adults.
Cognitive therapy (CT) will consist of 12 to 16 individual CT sessions on a weekly basis plus 3 booster sessions.
Comparador activo: Enhanced Usual Care
Enhanced usual care consists of the usual care that individuals receive for suicide prevention, plus assessment and referral services provided by project staff, and weekly phone calls provided by study therapists.
Enhanced usual care (EUC) will consist of the usual care that individuals receive for suicide prevention in the community, assessment and referral services provided by study staff, and weekly telephone calls lasting 15-30 minutes provided by study therapists to ensure patient safety and to provide some support.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Periodo de tiempo
Change in baseline suicidal ideation
Periodo de tiempo: baseline, 1, 3, 6, 9, 12 months
baseline, 1, 3, 6, 9, 12 months

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
depression
Periodo de tiempo: baseline, 1, 3, 6, 9, 12 months
baseline, 1, 3, 6, 9, 12 months
hopelessness
Periodo de tiempo: baseline, 1, 3, 6, 9, 12 months
baseline, 1, 3, 6, 9, 12 months
quality of life
Periodo de tiempo: baseline, 1, 3, 6, 9, 12 months
baseline, 1, 3, 6, 9, 12 months
social problem solving skills
Periodo de tiempo: baseline, 1, 3, 6, 9, 12 months
baseline, 1, 3, 6, 9, 12 months
complicated grief
Periodo de tiempo: baseline, 1, 3, 6, 9, 12 months
baseline, 1, 3, 6, 9, 12 months
reasons for living and dying
Periodo de tiempo: baseline, 1, 3, 6, 9, 12 months
baseline, 1, 3, 6, 9, 12 months
perceived social support
Periodo de tiempo: baseline, 1, 3, 6, 9, 12 months
baseline, 1, 3, 6, 9, 12 months
Cognitive Executive Functioning
Periodo de tiempo: baseline, 1, 3, 6, 9, 12 months
Executive functioning will be measured by scores on an Executive Functioning Interview, which measures skills such as planning, working memory, attention, inhibition, and mental flexibility.
baseline, 1, 3, 6, 9, 12 months

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio

1 de septiembre de 2011

Finalización primaria (Actual)

6 de abril de 2017

Finalización del estudio (Actual)

6 de abril de 2017

Fechas de registro del estudio

Enviado por primera vez

25 de agosto de 2011

Primero enviado que cumplió con los criterios de control de calidad

14 de febrero de 2012

Publicado por primera vez (Estimar)

17 de febrero de 2012

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

8 de junio de 2017

Última actualización enviada que cumplió con los criterios de control de calidad

7 de junio de 2017

Última verificación

1 de junio de 2017

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • R01MH086572-01A2 (Subvención/contrato del NIH de EE. UU.)
  • 1R01MH086572-01A2 (Subvención/contrato del NIH de EE. UU.)

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Ensayos clínicos sobre Cognitive Therapy

Suscribir